Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine: A Randomized Clinical Trial

NCT06974617 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT06974617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06974617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine: A Randomized Clinical Trial
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Recruiting
Start date
May 15, 2025
Completion date
October 1, 2025
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

botox, chronic migraine, sphenopalatine block